Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines

Go back to Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.11 +0.11 (1.10%)
Previous Close $10.00    52 Week High $9.23 
Open $9.89    52 Week Low $1.16 
Day High $10.15    P/E N/A 
Day Low $9.76    EPS $-0.30 
Volume 11,145,262       

BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 14.31 -0.51 (3.44%)
Previous Close $14.82    52 Week High $5.58 
Open $14.42    52 Week Low $3.60 
Day High $14.46    P/E N/A 
Day Low $14.30    EPS $0.00 
Volume 5,254,511       

SANOFI (NASDAQ: SNY) Delayed: 42.48 -0.66 (1.53%)
Previous Close $43.14    52 Week High $44.76 
Open $42.75    52 Week Low $36.81 
Day High $42.77    P/E N/A 
Day Low $42.34    EPS $0.00 
Volume 2,244,770